AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $258,000 | -16.5% | 5,600 | 0.0% | 0.01% | -17.6% |
| Q2 2021 | $309,000 | +6.9% | 5,600 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $289,000 | +18.9% | 5,600 | 0.0% | 0.02% | +13.3% |
| Q4 2020 | $243,000 | -18.7% | 5,600 | 0.0% | 0.02% | -37.5% |
| Q2 2020 | $299,000 | +12.0% | 5,600 | 0.0% | 0.02% | +26.3% |
| Q4 2019 | $267,000 | -4.3% | 5,600 | 0.0% | 0.02% | -13.6% |
| Q2 2019 | $279,000 | -26.2% | 5,600 | 0.0% | 0.02% | -29.0% |
| Q1 2019 | $378,000 | +46.5% | 5,600 | 0.0% | 0.03% | +29.2% |
| Q4 2018 | $258,000 | -40.3% | 5,600 | 0.0% | 0.02% | -31.4% |
| Q3 2018 | $432,000 | -8.5% | 5,600 | 0.0% | 0.04% | -12.5% |
| Q2 2018 | $472,000 | +3.1% | 5,600 | 0.0% | 0.04% | -2.4% |
| Q1 2018 | $458,000 | +43.1% | 5,600 | 0.0% | 0.04% | +41.4% |
| Q4 2017 | $320,000 | – | 5,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |